Top compounds associated with response to CRYGS


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.00013 1
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.00011 1
mRNA Vinblastine GDSC1000 pan-cancer AAC 2.8e-05 1
mRNA BMS-754807 CTRPv2 pan-cancer AAC -1.5e-06 1
Download CSV